These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moving Box Inc.
|
|
(Exact name of registrant as specified in its charter
|
|
Delaware
|
7812
|
27-1994406
|
||
|
(State or other jurisdiction of
incorporation or organization)
|
(Primary Standard Industrial
Classification Code Number)
|
IRS I.D.
|
|
222 E . Jones Ave. Wake Forest NC
|
27587
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
o |
Accelerated filer
|
o
|
|
Non-accelerated filer
|
o |
Smaller Reporting Company
|
x
|
| Index | |||
| Balance Sheets as of June 30, 2011 and March 31, 2011 | 3 | ||
|
Statements of Operations for the Three Months Ended June 30, 2011and 2010 and the Period from
January 1, 2010 (inception) through June 30, 2011
|
4 | ||
| Statement of Changes in Stockholders’ Deficit for the Three Months Ended June 30, 2011 and the Period from January 1, 2010 (inception) through June 30, 2011 | 5 | ||
| Statements of Cash Flows for the Three Months Ended June 30, 2011 and the Period from January 1, 2010 (inception) through June 30, 2011 | 6 | ||
| Notes to the Financial Statements | 7 |
|
June 30,
|
March 31,
|
|||||||
|
2011
|
2011
|
|||||||
| ASSETS | ||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash
|
$ | 9,618 | $ | 9,771 | ||||
| Total current assets | 9,618 | 9,771 | ||||||
|
TOTAL ASSETS
|
$ | 9,618 | $ | 9,771 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Loan payable - related party
|
$ | 110,200 | $ | 110,200 | ||||
|
Related party advances
|
171,250 | 154,250 | ||||||
|
Interest payable
|
10,189 | 7,991 | ||||||
| Total current liabilities | 291,639 | 272,441 | ||||||
|
STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||
|
Preferred stock, $0.000001 par value, 5,000,000 shares authorized; issued & outstanding -0-
|
- | - | ||||||
|
Common stock, $0.000001 par value, 95,000,000 shares authorized; issued & outstanding
|
7 | 7 | ||||||
|
6,500,000 and 4,500,000 as of June 30, 2011 and March 31, 2011, respectively
|
||||||||
|
Additional paid in capital
|
39,993 | 39,993 | ||||||
|
Deficit accumulated during the development stage
|
(322,021 | ) | (302,670 | ) | ||||
| Total stockholders' equity (deficit) | (282,021 | ) | (262,670 | ) | ||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
$ | 9,618 | $ | 9,771 | ||||
|
DEVELOPMENT STAGE
|
||||||||||||
|
FOR THE THREE
|
JANUARY 1, 2010 (inception)
|
|||||||||||
|
MONTHS ENDED
|
THROUGH
|
|||||||||||
|
JUNE 30, 2011
|
JUNE 30, 2010
|
JUNE 30, 2011
|
||||||||||
|
REVENUE
|
$ | - | $ | - | $ | - | ||||||
|
OPERATING EXPENSES
|
||||||||||||
|
Production costs
|
14,650 | 226,778 | 274,803 | |||||||||
|
Professional fees
|
- | 1,750 | 19,134 | |||||||||
|
General and administrative
|
4,701 | 8,950 | 28,084 | |||||||||
|
Total operating expenses
|
19,351 | 237,478 | 322,021 | |||||||||
|
NET INCOME (LOSS)
|
$ | (19,351 | ) | $ | (237,478 | ) | $ | (322,021 | ) | |||
|
BASIC AND DILUTED EARNINGS PER SHARE
|
$ | (0.00 | ) | $ | (0.05 | ) | ||||||
|
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING
|
6,500,000 | 4,500,000 | ||||||||||
|
Additional
|
Deficit
Accumulated
During the
|
|||||||||||||||||||
|
Common Stock
|
Paid-in
|
Development
|
||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Stage
|
Total
|
||||||||||||||||
|
Balance at January 1, 2010
|
- | $ | - | $ | - | $ | - | $ | - | |||||||||||
|
Stock issued to founders
|
4,500,000 | 5 | (5 | ) | - | - | ||||||||||||||
|
Net loss
|
- | - | - | (11,777 | ) | (11,777 | ) | |||||||||||||
|
Balance at March 31, 2010
|
4,500,000 | 5 | (5 | ) | (11,777 | ) | (11,777 | ) | ||||||||||||
|
Stock issued
|
2,000,000 | 2 | 39,998 | - | 40,000 | |||||||||||||||
|
Net loss
|
- | - | - | (290,893 | ) | (290,893 | ) | |||||||||||||
|
Balance at March 31, 2011
|
6,500,000 | 7 | 39,993 | (302,670 | ) | (262,670 | ) | |||||||||||||
|
Net loss (unaudited)
|
(19,351 | ) | (19,351 | ) | ||||||||||||||||
|
Balance at June 30, 2011 (unaudited)
|
6,500,000 | $ | 7 | $ | 39,993 | $ | (322,021 | ) | $ | (282,021 | ) | |||||||||
|
DEVELOPMENT STAGE
|
||||||||||||
|
FOR THE THREE
|
JANUARY 1, 2010
|
|||||||||||
|
MONTHS ENDED
|
THROUGH
|
|||||||||||
|
JUNE 30, 2011
|
JUNE 30, 2010
|
JUNE 30, 2011
|
||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||
|
Net loss
|
$ | (19,351 | ) | $ | (237,478 | ) | $ | (322,021 | ) | |||
|
Change in assets and liabilities
|
||||||||||||
|
Increase / Decrease in accrued liabilities
|
2,198 | 1,400 | 10,189 | |||||||||
|
Net cash used in operating activities
|
(17,153 | ) | (236,078 | ) | (311,832 | ) | ||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Cash received for issuance of stock
|
- | - | 40,000 | |||||||||
|
Loan payable - related party
|
- | 100,200 | 110,200 | |||||||||
|
Related party advances
|
17,000 | 116,650 | 171,250 | |||||||||
|
Borrowings of debt
|
18,991 | - | 18,991 | |||||||||
|
Repayments of debt
|
(18,991 | ) | - | (18,991 | ) | |||||||
|
Net cash provided by financing activities
|
17,000 | 216,850 | 321,450 | |||||||||
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
(153 | ) | (19,228 | ) | 9,618 | |||||||
|
|
||||||||||||
|
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
|
9,771 | 25,823 | - | |||||||||
|
|
||||||||||||
|
CASH AND CASH EQUIVALENTS - END OF PERIOD
|
$ | 9,618 | $ | 6,595 | $ | 9,618 | ||||||
| Supplemental Disclosures of Cash Flow Information | ||||||||||||
| Cash paid for income taxes | $ | - | $ | - | $ | - | ||||||
|
Cash paid for interest
|
$ | - | $ | - | $ | - | ||||||
| June 30, 2011 | December 31, 2010 | |||||||
| Net operating loss carryforwards | $ | (112,707 | ) | $ | (105,935 | ) | ||
| Valuation allowance | 112,707 | $ | (105,935 | ) | ||||
| Net deferred tax asset | $ | - | $ | - | ||||
|
·
|
The skill and creativity of the ownership to be fiscally responsible - “stretch every dollar” of our employees and their relationships with artists,
|
|
·
|
Our ability to develop new products that are impactful and distributive relationships,
|
|
·
|
The expansion and utilization of the Company’s catalog worldwide.
|
|
·
|
The acquisition of licenses to enable the Company to expand its offerings.
|
|
·
|
The effective and efficient distribution of the Company’s products
|
|
·
|
Costs of the Project
|
|
·
|
Costs to finance our business, including costs associated with distribution of the Movie, and of costs of becoming and staying a public company
|
|
o
|
We hope that we will generate operating revenues or raise additional funds after our Movie has been released to finance these costs. If we do no secure funds from such sources, Mr. Wilcken, Jr. has agreed to provide certain funding for these costs as further described in “Business,” below.
|
|
·
|
Payment to the Investors a Royalty Payment in an amount equal to $154,000.
|
|
·
|
Repayment of the Wilcken Note and any other amounts advanced to Moving Box or MBE by Wilcken on terms as specified in the Wilcken Note
|
| ▪ | In addition to amounts advanced under the Note, Wilcken agrees to provide if and when needed all funding for the Moving Box’s going and staying public in the U.S., including but not limited to legal, accounting, EDGAR, filing, corporate and other fees and expenses, if and when needed, regardless of whether or not Moving Box’s registration statement has been declared effective or it has secured a qualification for quotation of our securities on the OTC Bulletin Board. With respect to funding of Moving Box’s or MBE’s other operational costs and expenses, including costs associated with distribution of the Movie, Wilcken hereby agrees to provide all such funding if and when needed by Moving Box or MBE. There is no limit on the amount of Additional Funding which must be provided under this Agreement, and Wilcken agrees to provide all needed Additional Funding as provided above. Wilcken further represents that he has sufficient liquid assets to meet all of Funding obligations under the Agreement, [This Additional Funding Agreement is part of an overall Agreement among various parties with respect to the Movie dated March 21, 2011, as amended on May 17, 2011, as described in our S-1 Registration Statement.] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Exhibits.
|
|
Exhibit
No.
|
Document Description
|
|
10.1
|
Agreement with GMP Group
|
|
10.2
|
Agreement with 7 Worldwide
|
|
31.1
|
CERTIFICATION of CEO/CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
|
|
32.1*
|
CERTIFICATION of CEO/CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEYACT OF 2002
|
|
101.INS **
|
XBRL Instance Document
|
|
|
||
|
101.SCH **
|
XBRL Taxonomy Extension Schema Document
|
|
|
||
|
101.CAL **
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
||
|
101.DEF **
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
||
|
101.LAB **
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
||
|
101.PRE **
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
||
|
SIGNATURE
|
NAME
|
TITLE
|
DATE
|
|||
|
/s/ Andreas Wilcken, Jr.
|
Andreas Wilcken, Jr.
|
President
|
August 19, 2011
|
|||
|
SIGNATURE
|
NAME
|
TITLE
|
DATE
|
|||
|
/s/ Andreas Wilcken, Jr.
|
Andreas Wilcken, Jr.
|
President, Principal Executive Officer, Principal Financial Officer,
|
August 19, 2011
|
|||
| Principal Accounting Officer, Director |
|
Exhibit
No.
|
Document Description
|
|
10.1
|
Agreement with GMP Group
|
|
10.2
|
Agreement with 7 Worldwide
|
|
31.1
|
CERTIFICATION of CEO/CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
|
|
32.1*
|
CERTIFICATION of CEO/CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEYACT OF 2002
|
|
101.INS **
|
XBRL Instance Document
|
|
|
||
|
101.SCH **
|
XBRL Taxonomy Extension Schema Document
|
|
|
||
|
101.CAL **
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
||
|
101.DEF **
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
||
|
101.LAB **
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
||
|
101.PRE **
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|